For Researchers
Affymetrix Analysis Services
The CMM offers IVD, biotech and pharmaceutical companies cost-effective microarray analysis on pre-clinical samples in a CLIA-certified laboratory environment. The CMM is also CAP accredited and GLP-like environment.
Other fee for service technologies available from the CMM to clients interested in clinical trials and clinical test development include:
Genomics
- Real-time PCR capabilities (current)
- Automated, high-throughput, high density array analysis (current)
- High-throughput nucleic acid extraction and storage (May 2007)
- Biobanking: access to highly characterized patient specimens and data (in development)
Proteomics
- Multiplex measurements of protein biomarkers spanning the breadth of biology (May 2007)
- Tumor cell detection
- Detection of circulating tumor cells as an aid in monitoring metastatic breast cancer (October 2007)
Bioinformatics
- CMM provides access to Xenobase: a computational system that enables the systematic management of pre-clinical, clinical, demographic and biomedical information along with associated molecular data in its various forms.
Clients receive complete raw data set on gene expression, genotyping, or whatever service was provided. Additional clinical analysis and diagnosis services are also available. Data may also be subjected to analysis via Xenobase for enhanced utility of the generated results. The CMM offers a complete package of support for investigators seeking further testing and development options for their project.
Diagnostic Validation: Retrospective and Prospective
The CMM offers clients cost-effective validation of new tests, alpha and beta testing services and data reporting and analysis from a CLIA/CAP/GLP-like laboratory environment. A developing BioBank permits rapid retrospective analysis. A network of Spectrum Health hospitals in the region allows a wide variety of prospective studies. Van Andel Institute based bioinformatics capabilities permits in-depth analysis of generated results. The CMM offers a complete package of support for companies that seek to advance their projects through further testing, development and analysis.
For Service Requisitions
Please inquire to info@cmmdx.org
Fee Structure
Please inquire to info@cmmdx.org
The CMM offers physicians and their patients FDA-approved microarray based tests to examine genotypes and circulating tumor cell patterns. Our menu of services is constantly growing.
The CLIA-licensed, CAP accredited,
GLP-like environment CMM offers the IVD,
biotech and pharma communities a full array of cost-effective genomic,
proteomic and bioinformatic services. Contact us about validation,
testing and data analysis.
© Copyright 2008 Center for Molecular Medicine